VITUZ Drug Patent Profile
Which patents cover Vituz, and when can generic versions of Vituz launch?
Vituz is a drug marketed by Persion and is included in one NDA.
The generic ingredient in VITUZ is chlorpheniramine maleate; hydrocodone bitartrate. There is one drug master file entry for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VITUZ?
- What are the global sales for VITUZ?
- What is Average Wholesale Price for VITUZ?
Summary for VITUZ
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 1,264 |
| DailyMed Link: | VITUZ at DailyMed |
US Patents and Regulatory Information for VITUZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Persion | VITUZ | chlorpheniramine maleate; hydrocodone bitartrate | SOLUTION;ORAL | 204307-001 | Feb 20, 2013 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
